Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Detecting Extracapsular Extension in Intermediate and High - Risk Prostate Cancer

Overview

Journal Int Braz J Urol

Specialty Urology

Date 2018 Mar 24

PMID 29570254

Citations 15

Authors

Cristina Dominguez

Mauricio Plata

Juan Guillermo Catano

Mauricio Palau

Diego Aguirre

Jorge Narvaez

Stephanie Trujillo

Felipe Gomez

Carlos Gustavo Trujillo

Juan Ignacio Caicedo

Camilo Medina

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the diagnostic performance of preoperative multiparametric magnetic resonance imaging (mp-MRI) as a predictor of extracapsular extension (ECE) and unfavorable Gleason score (GS) in patients with intermediate and high-risk prostate cancer (PCa).

Materials And Methods: Patients with clinically localized PCa who underwent radical prostatectomy (RP) and had preoperative mp-MRI between May-2011 and December-2013. Mp-MRI was evaluated according to the European Society of Urogenital Radiology MRI prostate guidelines by two different readers. Histopathological RP results were the standard reference.

Results: 79 patients were included; mean age was 61 and median preoperative prostate-specific antigen (PSA) 7.0. On MRI, 28% patients had ECE evidenced in the mp-MRI, 5% seminal vesicle invasion (SVI) and 4% lymph node involvement (LNI). At RP, 39.2% had ECE, 26.6% SVI and 12.8% LNI. Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of mp-MRI for ECE were 54.9%, 90.9%, 76%, 81% and 74.1% respectively; for SVI values were 19.1%, 100%, 77.3%, 100% and 76.1% respectively and for LNI 20%, 98.4%, 86.7%, 66.7% and 88.7%.

Conclusions: Major surgical decisions are made with digital rectal exam (DRE) and ultrasound studies before the use of Mp-MRI. This imaging study contributes to rule out gross extraprostatic extension (ECE, SVI, LNI) without competing with pathological studies. The specificity and NPV are reasonable to decide surgical approach. A highly experienced radiology team is needed to provide accurate estimations of tumor extension and aggressiveness.

Citing Articles

Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis.

Thomas M, Murali S, Simpson B, Freeman A, Kirkham A, Kelly D BMJ Open. 2023; 13(8):e074009.

PMID: 37607794 PMC: 10445392. DOI: 10.1136/bmjopen-2023-074009.

The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer.

Drobner J, Kaldany A, Shah M, Ghodoussipour S Cancers (Basel). 2023; 15(14).

PMID: 37509395 PMC: 10378204. DOI: 10.3390/cancers15143734.

Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients.

Laudicella R, Skawran S, Ferraro D, Muhlematter U, Maurer A, Grunig H Insights Imaging. 2022; 13(1):75.

PMID: 35426518 PMC: 9012878. DOI: 10.1186/s13244-022-01217-4.

Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review.

Michael J, Neuzil K, Altun E, Bjurlin M Cancer Manag Res. 2022; 14:937-951.

PMID: 35256864 PMC: 8898014. DOI: 10.2147/CMAR.S283299.

The Quantitative Assessment of Using Multiparametric MRI for Prediction of Extraprostatic Extension in Patients Undergoing Radical Prostatectomy: A .

Li W, Sun Y, Wu Y, Lu F, Xu H Front Oncol. 2021; 11:771864.

PMID: 34881183 PMC: 8645791. DOI: 10.3389/fonc.2021.771864.

References

Heidenreich A . Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol. 2011; 59(4):495-7. DOI: 10.1016/j.eururo.2011.01.013. View

Wang L, Hricak H, Kattan M, Schwartz L, Eberhardt S, Chen H . Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol. 2006; 186(3):743-8. DOI: 10.2214/AJR.04.1682. View

Nepple K, Rosevear H, Stolpen A, Brown J, Williams R . Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol. 2011; 31(5):601-6. DOI: 10.1016/j.urolonc.2011.05.004. View

Hegde J, Chen M, Mulkern R, Fennessy F, DAmico A, Tempany C . Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012; 85(2):e101-7. PMC: 3545042. DOI: 10.1016/j.ijrobp.2012.08.032. View

Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V . Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011; 59(6):962-77. DOI: 10.1016/j.eururo.2011.02.034. View

Jeong I, Lim J, You D, Kim M, Choi H, Kim J . Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies. J Urol. 2013; 190(6):2054-60. DOI: 10.1016/j.juro.2013.06.035. View

Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbo H, Hung A . Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer. J Urol. 2014; 193(2):466-72. DOI: 10.1016/j.juro.2014.08.084. View

de Rooij M, Hamoen E, Futterer J, Barentsz J, Rovers M . Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol. 2014; 202(2):343-51. DOI: 10.2214/AJR.13.11046. View

Bastian P, Carter B, Bjartell A, Seitz M, Stanislaus P, Montorsi F . Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol. 2009; 55(6):1321-30. DOI: 10.1016/j.eururo.2009.02.028. View

10.

Moore C, Robertson N, Arsanious N, Middleton T, Villers A, Klotz L . Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol. 2012; 63(1):125-40. DOI: 10.1016/j.eururo.2012.06.004. View

11.

Partin A, Mangold L, Lamm D, Walsh P, Epstein J, Pearson J . Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001; 58(6):843-8. DOI: 10.1016/s0090-4295(01)01441-8. View

12.

Moore C, Ridout A, Emberton M . The role of MRI in active surveillance of prostate cancer. Curr Opin Urol. 2013; 23(3):261-7. DOI: 10.1097/MOU.0b013e32835f899f. View

13.

Somford D, Hamoen E, Futterer J, van Basten J, Hulsbergen-van de Kaa C, Vreuls W . The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol. 2013; 190(5):1728-34. DOI: 10.1016/j.juro.2013.05.021. View

14.

Rosenkrantz A, Lim R, Haghighi M, Somberg M, Babb J, Taneja S . Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol. 2013; 201(4):W612-8. DOI: 10.2214/AJR.12.10173. View

15.

Borofsky S, George A, Gaur S, Bernardo M, Greer M, Mertan F . What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology. 2017; 286(1):186-195. PMC: 5749595. DOI: 10.1148/radiol.2017152877. View

16.

Feng T, Sharif-Afshar A, Smith S, Miller J, Nguyen C, Li Q . Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer. Urol Oncol. 2014; 33(3):109.e15-22. DOI: 10.1016/j.urolonc.2014.11.007. View

17.

Boesen L, Chabanova E, Logager V, Balslev I, Mikines K, Thomsen H . Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology. Eur Radiol. 2014; 25(6):1776-85. DOI: 10.1007/s00330-014-3543-9. View

18.

Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian K, Udo K . Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int. 2011; 109(9):1315-22. PMC: 3270152. DOI: 10.1111/j.1464-410X.2011.10612.x. View

19.

Ouzzane A, Puech P, Villers A . How accurately can MRI detect indolent disease?. Curr Opin Urol. 2014; 24(3):264-9. DOI: 10.1097/MOU.0000000000000047. View

20.

Ghai S, Trachtenberg J . MRI-guided biopsies and minimally invasive therapy for prostate cancer. Indian J Urol. 2015; 31(3):209-16. PMC: 4495495. DOI: 10.4103/0970-1591.159615. View